December - 202019velocity, step length, and single-limb support. Based on these parameters, a therapist calibrates a footworn device using proprietary methodology to attach convex pods to rails built into the bottom of the device. The individual is re-tested for pain and gait function and the device is adjusted until it has optimized its impact.Personalized for each individual, the device is a complement to daily activities at home or work. By wearing the device for about an hour a day while going about normal activity, patients have seen demonstrable improvement in both pain and gait patterns. One of the major advantages of AposHealth® is that the program allows for at-home treatment with up to 5 visits a year with a healthcare professional. This may save the patients from the trouble of physical office visits, and reduce their potential exposure to COVID-19 from frequent visits to the clinics and doctors. To date, the product has been used by more than 100,000 patients globally, to temporarily reduce pain, improve walking patterns, and elevate quality of life. Backing it up are more than 60 publications in peer reviewed journals including a recent publication in JAMA showing that 83% knee osteoarthritis patients treated with AposHealth® reported more than a 50% reduction in pain compared to 42% in an active control group.Continuing to bring new technologies and solutions to the marketplace, AposHealth® will focus on improving mobility and function through advanced motion analysis and functional gait retraining anytime, anywhere. The company is also looking forward to enabling its clients to do visual and laboratory gait assessments using sensors with the help of their phone. With a strong focus on research, AposHealth® will continue to work with leading academic medical centers to perform additional clinical trials on the effectiveness and outcomes of AposHealth® in various gait-related conditions. "Our mission is to give individuals suffering from gait-related conditions the power to move by combining science and innovation to help them live an active, rich, and happy life" concludes Dr. Cliff Bleustein. AposHealth® is a clinically proven, non-invasive, FDA-cleared, solution for knee osteoarthritis--without changing patients' daily routine and may act as a potential alternative to surgery. The treatment may result in improved mobility, high patient satisfaction rate, and economic benefits to payors, providers, and participating practitioners
< Page 9 | Page 11 >